Showing results (21-30 of 6,954) with videos related to

Sort By:
Pageof 696
Frontiers in Pharmacology|June 16, 2025
Enhanced resistance to <i>Listeria</i> infection in mice surviving sepsis: the role of lipid metabolism and myeloid cell reprogrammingHaruki Watanabe, Tengfei Song, Jaewoo Choi, et al.
Oncogene|February 9, 2023
Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesisYoujin Na, Ashley Hall, Yanan Yu, et al.
Oncogene|December 14, 2018
STAT3 inhibition reduces macrophage number and tumor growth in neurofibromaJonathan S Fletcher, Mitchell G Springer, Kwangmin Choi, et al.
Neuro-Oncology|October 23, 2019
Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporationSmruti K Patel, Rachel M Hartley, Xin Wei, et al.
Science Advances|October 16, 2024
Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenanceJay Pundavela, Samantha Anne Dinglasan, Melissa Touvron, et al.
Scientific Reports|September 8, 2017
Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancerTilak Khanal, Kwangmin Choi, Yuet-Kin Leung, et al.
Cancer Discovery|August 31, 2021
Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic SyndromesYasushige Aoyagi, Yoshihiro Hayashi, Yuka Harada, et al.
Oncogene|June 3, 2021
WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growthCraig S Thomson, Jay Pundavela, Melissa R Perrino, et al.
Acta Neuropathologica Communications|May 12, 2026
Decreased PP2A expression and activity represent a therapeutic target for plexiform neurofibromaMinghui Yue, Yixiao Wang, Jiabao Gu, et al.
Haematologica|April 27, 2023
Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammationTomoya Muto, Callum S Walker, Puneet Agarwal, et al.
Pageof 696